Neuroscience
Fluorescent markers provide a way to analyze and manipulate oligodendrocytes
Published in Gene Therapy Weekly, July 21st, 2005
According to a study from the United States, "the ability to identify oligodendrocytes in culture, in fixed tissue, and in vivo using unique markers is a requisite step to understanding their responses in any damage, recovery, or developmental process. Their nuclei are readily seen in histological preparations of healthy white and gray matter, and their cell bodies can be reliably identified with a variety of immunocytochemical markers."
"However, there is little consensus regarding optimal methods to assess oligodendrocyte survival or morphology under experimental injury...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-07-21)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
Chimeraplasts offer short-term correction of the apolipoprotein E4 gene - Gene Transfer
Viral 2A peptide stabilizes monoclonal antibody at therapeutic levels - Hematology
Cell type and developmental stage guide the efficacy of RNA interference - Oncology
Interleukin-27 transduction prevents new tumor formation in study animals - Pediatric Oncology
S100A4 antisense oligodeoxynucleotide chokes neuroblastoma cell invasion - Angioplasty
Locally delivered decoy nucleotides fail to staunch restenosis in rabbits - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
